人工肺:医療機器パイプライン分析2018

◆英語タイトル:Artificial Lung - Medical Devices Pipeline Assessment, 2018
◆商品コード:GDME0511EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年2月15日
◆ページ数:37
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Artificial Lung – Medical Devices Pipeline Assessment, 2018
Summary

GlobalData’s Medical Devices sector report, “Artificial Lung – Medical Devices Pipeline Assessment, 2018″ provides an overview of Artificial Lung currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Lung pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Artificial Lung under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Lung and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Lung under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Artificial Lung Overview 5
3 Products under Development 6
3.1 Artificial Lung – Pipeline Products by Stage of Development 6
3.2 Artificial Lung – Pipeline Products by Territory 7
3.3 Artificial Lung – Pipeline Products by Regulatory Path 8
3.4 Artificial Lung – Pipeline Products by Estimated Approval Date 9
3.5 Artificial Lung – Ongoing Clinical Trials 10
4 Artificial Lung – Pipeline Products under Development by Companies 11
4.1 Artificial Lung Companies – Pipeline Products by Stage of Development 11
4.2 Artificial Lung – Pipeline Products by Stage of Development 12
5 Artificial Lung Companies and Product Overview 13
5.1 ALung Technologies Inc Company Overview 13
5.1.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Breethe, Inc. Company Overview 17
5.2.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Case Western Reserve University Company Overview 18
5.3.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Haemair Ltd Company Overview 19
5.4.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Lung Biotechnology PBC Company Overview 20
5.5.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 McGowan Institute for Regenerative Medicine Company Overview 21
5.6.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 MedArray Inc. Company Overview 23
5.7.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Michigan Critical Care Consultants, Inc. Company Overview 24
5.8.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.9 Miromatrix Medical Inc Company Overview 25
5.9.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 The Charles Stark Draper Laboratory Inc Company Overview 26
5.10.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 University of California San Francisco Company Overview 27
5.11.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 27
5.12 University of Michigan Company Overview 28
5.12.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 28
5.13 University of Pittsburgh Company Overview 29
5.13.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 29
5.14 Xenios AG Company Overview 30
5.14.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 30
6 Artificial Lung- Recent Developments 32
6.1 Sep 27, 2017: ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the US Market 32
6.2 Apr 25, 2017: ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS 33
7 Appendix 34
7.1 Methodology 34
7.2 About GlobalData 37
7.3 Contact Us 37
7.4 Disclaimer 37

1.1 List of Tables
Table 1: Artificial Lung - Pipeline Products by Stage of Development 6
Table 2: Artificial Lung - Pipeline Products by Territory 7
Table 3: Artificial Lung - Pipeline Products by Regulatory Path 8
Table 4: Artificial Lung - Pipeline Products by Estimated Approval Date 9
Table 5: Artificial Lung - Ongoing Clinical Trials 10
Table 6: Artificial Lung Companies - Pipeline Products by Stage of Development 11
Table 7: Artificial Lung - Pipeline Products by Stage of Development 12
Table 8: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 13
Table 9: Hemolung RAS - Product Status 13
Table 10: Hemolung RAS - Product Description 13
Table 11: ALung Technologies Inc - Ongoing Clinical Trials Overview 14
Table 12: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support 15
Table 13: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD 15
Table 14: Hemolung RAS - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation 15
Table 15: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure 16
Table 16: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 17: OXY-1 - Product Status 17
Table 18: OXY-1 - Product Description 17
Table 19: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 18
Table 20: Portable Artificial Lung - Product Status 18
Table 21: Portable Artificial Lung - Product Description 18
Table 22: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 23: Portable Artificial Lung - Product Status 19
Table 24: Portable Artificial Lung - Product Description 19
Table 25: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 26: Implantable Artificial Lung - Product Status 20
Table 27: Implantable Artificial Lung - Product Description 20
Table 28: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 21
Table 29: Biohybrid Artificial Lung - Product Status 21
Table 30: Biohybrid Artificial Lung - Product Description 21
Table 31: Chronic Artificial Lung - Product Status 22
Table 32: Chronic Artificial Lung - Product Description 22
Table 33: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 34: Artificial Lung Fiber - Product Status 23
Table 35: Artificial Lung Fiber - Product Description 23
Table 36: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 37: BioLung - Product Status 24
Table 38: BioLung - Product Description 24
Table 39: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 40: Miromatrix Artificial Lung - Product Status 25
Table 41: Miromatrix Artificial Lung - Product Description 25
Table 42: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 43: Silicone-Based Microfluidic Artificial Lung - Product Status 26
Table 44: Silicone-Based Microfluidic Artificial Lung - Product Description 26
Table 45: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 27
Table 46: Neonatal ECMO Device - Product Status 27
Table 47: Neonatal ECMO Device - Product Description 27
Table 48: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 28
Table 49: M-Lung - Product Status 28
Table 50: M-Lung - Product Description 28
Table 51: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 29
Table 52: Paracorporeal Ambulatory Assist Lung - Product Status 29
Table 53: Paracorporeal Ambulatory Assist Lung - Product Description 29
Table 54: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 30
Table 55: i-lung - Product Status 30
Table 56: i-lung - Product Description 30
Table 57: Xtralung - Product Status 31
Table 58: Xtralung - Product Description 31
Table 59: Glossary 36

1.2 List of Figures
Figure 1: Artificial Lung - Pipeline Products by Stage of Development 6
Figure 2: Artificial Lung - Pipeline Products by Territory 7
Figure 3: Artificial Lung - Pipeline Products by Regulatory Path 8
Figure 4: Artificial Lung - Pipeline Products by Estimated Approval Date 9
Figure 5: Artificial Lung - Ongoing Clinical Trials 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 人工肺:医療機器パイプライン分析2018(Artificial Lung - Medical Devices Pipeline Assessment, 2018)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆